News from industry food companies.

Washington, D.C.—Grassroots efforts are helping to fight the U.S. Food and Drug Administration’s (FDA) draft guidance for new dietary ingredients (NDIs).

Nothing is more frustrating than managing staff members who cut corners, do the bare minimum and contribute little to the team. You can’t force your workers to be as passionate as you are about your business, but you can do a lot to motivate them.

High fructose corn syrup (HFCS), the oft-maligned and omnipresent sweetening agent, may be in for a major change if corn refiners get their way. The ingredient itself, frequently cited for its overconsumption and the target of many recent consumer health initiatives, won’t undergo a transformation, but the way it’s referred to on food labels could, pending a U.S. Food and Drug Administration (FDA) decision.

Jarrow Formulas, Inc. and James Gormley of Citizens for Health organized a tactical meeting during Expo East, with the hopes of encouraging industry members to take a stronger stand against the recently proposed guidance on new dietary ingredients (NDIs), and to consider formation of a new trade association. In attendance were some of the industry’s largest and most influential supplement makers, retailers, and raw materials suppliers, as well as interested observers such as the founder of the American Botanical Council.

More than 20,000 industry members headed to Baltimore for the chance to learn and grow at Natural Products Expo East. Once again co-located with All Things Organic-BioFach America, the Organic Summit, and Healthy Baking, the show was held at the Baltimore Convention Center from September 21 to 24.

The hearts of many were heavy with news of the passing of John R. Carlson. He was 77.

green schools

To prepare for a future economy likely to be driven by environmental jobs and innovation, today’s children will need a green-centric education.

cocoa

New meta-analysis from British Medical Journal (BMJ) shows that chocolate could in fact reduce the risk of cardiometabolic disorders, such as heart disease and diabetes.